General medical practice activities
ENDOKRINOLOGI OG INDREMEDISIN AS
Revenue 2024
NOK 1.7m
Operating profit
NOK −727,000
Equity
NOK −721,000
Incorporated
2024
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 1.7m | |
| Total operating costs | 2.4m | |
| Operating profit (EBIT) | −727k | |
| Net financial items | −18k | |
| Profit for the year | −746k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 3.9m | |
| of which current assets | 517k | |
| Equity | −721k | |
| Total liabilities | 4.6m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.